Actualités (185)

Biophytis S A : lance l'étude clinique de phase 2 OBA dans l'obésité avec BIO101 (20-hydroxyecdysone) PU
Biophytis : protocole de phase 3 dévoilé dans la sarcopénie CF
Biophytis S A : Document AMF CP. 2024DD953457 PU
Biophytis S A : Document AMF CP. 2024DD953409 PU
Biophytis S A : Document AMF CP. 2024DD953438 PU
Biophytis S A : Document AMF CP. 2024DD953337 PU
Biophytis SA : succès de l'augmentation de capital AO
Biophytis S A : Communique de Presse PU
Biophytis S A : Communique de Presse PU
Biophytis S.A. annonce des changements au sein de son équipe de direction CI
Biophytis: accord de la FDA pour l'étude Sara-31 aux Etats-unis AO
Biophytis S A : Communique de Presse PU
Biophytis : demande d'autorisation pour l'étude Sara-31 CF
Biophytis S A : Résultats de l’Assemblée Générale Mixte du 17 avril 2023 PU
Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ('ADR') EQ
Biophytis présente les résultats positifs de Phase 2-3 COVA à la 21ème Conférence « Lung Science » - ERS 2023 EQ
Biophytis annonce la signature d’un accord-cadre avec Intsel Chimos, laboratoire pharmaceutique qui exploitera Sarconeos (BIO101) en France pour le traitement des formes sévère de COVID-19 EQ
Biophytis: Biophytis démarre le processus règlementaire de demande d’autorisation d’accès précoce en France auprès de la Haute Autorité de Santé (HAS) pour le traitement avec Sarconeos (BIO101) des fo EQ
Biophytis annonce la convocation d’une assemblée générale mixte le 30 mars 2023 EQ
Biophytis S A : annonce les résultats finaux positifs de son étude COVA de phase 2-3 avec Sarconeos (BIO101) dans les formes sévères de COVID-19 PU
Biophytis: Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 EQ
Biophytis rapporte l’analyse post-hoc positive de l’étude de phase 2-3 COVA soutenant fortement le potentiel thérapeutique de Sarconeos (BIO101) dans les formes sévères de la COVID-19 EQ
Biophytis publie ses principaux agrégats financiers au 30 juin 2022, annonce un retraitement des états financiers publiés au 31 décembre 2021 et fait un point sur les développements opérati EQ
Biophytis participates in H.C. Wainwright 24th Annual Global Investment Conference EQ
Biophytis : des résultats prometteurs contre le covid CF
Biophytis annonce les premiers résultats très prometteurs  de l’étude de phase 2-3 COVA dans l’insuffisance respiratoire liée à la COVID-19 EQ
Biophytis SA fera le point sur le développement de Sarconeos (BIO101) dans le Covid-19 lors du 4e Sommet annuel des thérapeutiques de la longévité CI
Biophytis présente le développement de Sarconeos (BIO101) en Phase 3 dans le traitement de la Sarcopénie au 15ème congrès international SCWD EQ
Biophytis S A : Résultats des votes de l’AGM du 21 juin 2022 – nouvelle résolution PU
Biophytis: Résultats de l’Assemblée Générale Mixte du 21 juin 2022 Adoption de l’ensemble des résolutions à titre ordinaire et extraordinaire présentées par la Société EQ
Biophytis : de nouvelles données à venir dans la SMA CF
Biophytis présente des données précliniques d’efficacité de Sarconeos (BIO101) dans l’Amyotrophie Spinale (SMA), une maladie neuromusculaire rare EQ
Biophytis annonce sa participation à la BIO International Convention de San Diego du 13 au 16 juin EQ
Biophytis S A : Lettre aux actionnaires individuels au porteur PU
Biophytis : point d'étape sur le développement clinique de Sarconeos (BIO101) EQ
Biophytis annonce ses résultats opérationnels et financiers 2021 et fait un point sur ses perspectives 2022 EQ
Biophytis annonce la nomination de Philippe Rousseau au poste de Directeur Administrateur et Financier EQ
Biophytis a reçu l'approbationBiophytis a reçu l'approbation de l'ANVISA (Brésil) pour donner accès à Sarconeos (BIO101) aux patients COVID-19 hospitalisés, dans le cadre d'un programme d'accès élargi EQ
Biophytis : réunion FDA pour les résultats de Sarconeos CF
Biophytis: Rencontre prévue avec la FDA pour faire avancer le développement de Sarconeos (BIO101) dans la sarcopénie de la phase 2 à la phase 3 EQ
Biophytis obtient une nouvelle structure de prêt de 10 M? avec Kreos Capital EQ
Biophytis annonce la reprise du recrutement dans les centres aux Etats-Unis pour l'étude COVA de phase 2-3 avec Sarconeos (BIO101) dans la COVID-19 EQ
Biophytis S A : Stanislas VEILLET revient en vidéo sur la préparation active de la commercialisation de Sarconeos pour le premier semestre 2021 PU
Biophytis S A : Interview réalisée par Didier Testot Fondateur LA BOURSE ET LA VIE TV Stanislas Veillet, PDG de Biophytis, revient sur les premiers résultats de l’étude clinique de phase 2 SARA-INT avec Sarconeos (BIO101) dans la sarcopénie et envisage un développement en phase 3. Voir l'interview sur labourseetlavie.com PU
Biophytis S A : annonce les premiers résultats de l’étude de phase 2 SARA-INT avec Sarconeos (BIO101) dans la SarcopenieLire le communiqué de presse PU
1234SuivantTout voir

Insiders

Photo Stanislas Veillet
Stanislas Veillet

Stanislas Veillet is the founder.
He founded Biophytis SA in 2006 and currently holds the title of Chairman, President & Chief Executive Officer.
He is also currently the Chairman of Biophytis, Inc. and an Independent Director at Drone Volt SA. In the past, he worked as a Research Director at Danone SA, Pharmacia SAS, and Cargill France SAS.
He obtained a doctorate degree from AgroParisTech.


Photo Stanislas de Gramont
Stanislas de Gramont

Stanislas de Gramont is currently the Chief Executive Officer at SEB SA since 2022.
He is also the Chairman at Lagostina SpA, Co-Chairman at SEB Développement SAS, Chairman at Groupe Seb Media SAS, Director at Zhejiang Supor Co., Ltd., Director at Groupe SEB Retailing SAS, and Director at StoreBound LLC.
Previously, he served as the Chief Executive Officer at Suntory Beverage & Food Europe Ltd.
and Chairman-Supervisory Board at WMF Retail GmbH.
He completed his undergraduate degree at ESSEC Business School.




Photo Eloïse Catherine Brigitte Veillet
Eloïse Catherine Brigitte Veillet

Eloïse Catherine Brigitte Veillet worked as an Analyst at Société Générale SA (UK) from 2008 to 2012.
She then worked as a Senior Analyst at Marble Bar Asset Management LLP from 2012 to 2014.
She also worked as an Analyst at SG Securities (Paris) SAS and as a Senior Consumer Analyst at DSAM Partners LLP.




Photo François Veillet
François Veillet

François Veillet was the Chairman of Technologies innovatrices d’imagerie, Inc.


Photo Ryan Veillet
Ryan Veillet

Ryan Veillet currently works as the President of Foundation Farms Corp.



Photo Jean Pierre Veillet
Jean Pierre Veillet

Jean Pierre Veillet founded Jean-Pierre Veillet Siteworks, Inc. in 1994.



Photo Stanislas Gaillard
Stanislas Gaillard

Stanislas Gaillard - Partner Stanislas Gaillard joined Equistone in 1998.
Prior to this, he gained experience at Arthur Andersen where he dealt with companies in the industry, food and distribution sectors.
Stanislas has worked on a number of transactions including the spin-off of Médi-Partenaires, a leading French private hospital operator focused on medicine, surgery and obstetrics, the buyout of Martek Power a leading manufacturer of power conversion products for high technological industries and the buyout of Unither, the world-leading manufacturer of sterile pharmaceutical unit doses using Blow-Fill-Seal technology (BFS).
He is currently a member of the Supervisory Boards of Dugas, GSCM Groupe and Vulcain Ingénierie.
In addition to his investment and portfolio responsibilities, Stanislas also co-ordinates LBO NET, which is an association of buyout professionals (lawyers, accountants, private equity houses, mezzanine and senior debt lenders) that monitors the French buyout market.
Stanislas is a business school graduate with specialisation in corporate finance.
He also holds a degree in accounting (DESCF).


Photo Stanislas Michael Yassukovich
Stanislas Michael Yassukovich

Stanislas Michael Yassukovich currently works at Folio Corporate Finance Ltd., as Chairman.
Mr. Yassukovich also formerly worked at Telewest Communications Plc, as Deputy Chairman from 1999 to 2003, Merrill Lynch International, as Chairman from 1985 to 1991, Prometheus Energy Co., as Non-Executive Chairman, Manek Investment Management Ltd., as Chairman, London Stock Exchange Group plc, as Deputy Chairman from 1986 to 1989, Bristol & West Plc, as Vice Chairman from 1991 to 1999, Henderson EuroTrust Plc, as Chairman, EASDAQ NV, as Chairman from 1997 to 2000, ABC International Bank Plc, as Deputy Chairman, Cayzer Continuation PCC Ltd., as Chairman, and Securities Association of China, as Chairman from 1987 to 1991.











Photo Stanislas Bouchard
Stanislas Bouchard

Stanislas Bouchard currently works at Cristalco SAS, as Chief Executive Officer, Cristalco, as Chief Executive Officer from 1998, Eurosugar SAS, as Commercial Director from 2011, and SA Gardel, as Director from 2016.


Photo Stanislas Jean Rotman
Stanislas Jean Rotman

Dr. Stanislas J.
Rotman is a Founding Partner & Chief Executive Officer at Nevastar Finance Ltd.
He worked as an Investment Professional in the Investment Management Division of Goldman Sachs in New York, Zürich and London.
Dr. Rotman received his Chartered Financial Analyst (CFA) designation and holds an MBA in Finance from Cornell University (New York).
He is a Member of the CFA Institute and the CFA Society of the UK.
He is also a Doctor of Medicine and practiced surgery.


Photo Stanislas Piot
Stanislas Piot

Stanislas Piot served as the Chief Financial Officer & Head-Investor Relations at Stentys SA and as the Chief Financial Officer at QIAGEN Marseille SA. He also served as the Chief Financial Officer at Balyo SA from 2017 to 2019.
Piot received an undergraduate degree from Université Paris II Panthéon Assas.




Photo Stanislas M. Evva
Stanislas M. Evva

Stanislas M.
Evva
is the founder and current Chairman of Watchdog System SAS, which is founded in 2014.









Photo Stanislas Martin
Stanislas Martin

Stanislas Martin has held director positions at E D F Trading Ltd.
and EDF Trading North America LLC.






Photo Stanislas Augem
Stanislas Augem

Stanislas Augem served as an Independent Director at Nexity SA from 2014 to 2016.


Photo Stanislas Bressange
Stanislas Bressange

Stanislas Bressange has worked as a Director at Jean & Dominique Ensarguet since 2006 and currently holds the position of Chief Technology Officer at Vaudoise Assurances Holding SA since 2021.




Photo Stanislas Archambault
Stanislas Archambault

Stanislas Archambault is currently working as the Executive Director-Operational & Digital Marketing at Interparfums since 2005.
He previously worked as the Managing Director-Luxury Brands at Inter Parfums, Inc. Mr. Archambault completed his undergraduate degree at Instituts d'Études Avancées.



Photo Stanislas Coüasnon
Stanislas Coüasnon

Stanislas Coüasnon worked as an Associate at Fondations Capital France SASU from 2018 to 2019.









Photo Stanislas Subra
Stanislas Subra

Stanislas Subra worked as a Senior Investment Manager at Mutuelle d'Assurances du Corps de Santé Français from 2010 to 2022.
He also served as a Board Member at Smartadserver SAS from 2015 to 2021, and held Board Member positions at Mediawan SAS, Gleamer SAS, You&MrJones LLC, and Wellium SAS from 2018 to 2022.
Prior to his career, he earned an undergraduate degree from Université Paris II Panthéon Assas in 2006.



Photo Henry Stanislas
Henry Stanislas

Henry Stanislas currently works as a Director at easyHotel Plc.





Photo Stanislas Zuin
Stanislas Zuin

Stanislas Zuin is currently the Vice Chairman at Aéroport International de Genève.





Photo Vanessa Stanislas
Vanessa Stanislas

Vanessa Stanislas has worked as a trustee for The Papworth Trust since 2017.












Photo Stanislas Lavorel
Stanislas Lavorel

Stanislas Lavorel is the founder of Lavorel Medicare SA, established in 2012.
He is currently the Chairman of LvL Medical Paris et Nord SAS, Chairman-Management Board of Lavorel Groupe SA, Chairman of Chateau Des Ravatys SAS, and Director of LVL Maintenance et Logistique, LVL Home Service SA, LVL Medical Corse SA, Potinière SASU, Medivalys SA, Murs du Luxe SARL, and Supergab SARL.
His former positions include Director & Chief Executive Officer of LVL Médical Centre Est, Chief Executive Officer of JCL Finances SASU, Chairman of LVL Medical Sud-Ouest SAS, and Chief Operating Officer of LVL Médical Groupe SA from 1997 to 2010.


Photo Stanislas Laurent
Stanislas Laurent

Stanislas Laurent is currently the Chairman & Co-Chief Executive Officer at Hofmann SL and a Partner at Highland Capital Partners (UK) Management Ltd.
He previously served as the President & Chief Executive Officer at PhotoBox SAS, PhotoBox Ltd., and PhotoBox Holdco Ltd.
He was also an Independent Non-Executive Director at Pets At Home Group Plc.
Additionally, he was a Member-Supervisory Board at 11 88 0 Solutions AG from 2005 to 2011 and a Principal at Qxl Plc.
He briefly served as the Chief Operating Officer at Aol Europe in 2006.
Mr. Laurent holds an MBA degree from Harvard University.







Photo Stanislas Choiseau
Stanislas Choiseau

Stanislas Choiseau has worked as Chairman & CEO at Groupe ATGT SA since 2011.
He is also currently the Chairman of ATGT Geometre-Expert SC and Director at Bureau d'Etudes et de Recherches Pour l'Industrie Moderne BE since 2013.






Photo Stanislas Kervyn
Stanislas Kervyn

Stanislas Kervyn is currently the Head of Compliance at NB Renaissance Partners since 2019.
Prior to this, he worked as the Chief Compliance Officer at Edmond de Rothschild Asset Management (Luxembourg) SA from 2008 to 2018.
He completed his undergraduate degree from Université Catholique de Louvain in 1990 and obtained an MBA from Cornell University Graduate School in 1991.


Photo Stanislas Guerini
Stanislas Guerini

Stanislas Guerini currently works at Government of France, as Minister of Transformation & Public Service.




Photo Stanislas d'Audiffret
Stanislas d'Audiffret

Stanislas d'Audiffret worked as a Senior Director-Debt Advisory at bfinance UK Ltd.
and as a Principal at HSBC Bank Plc and Natixis SA. He obtained an undergraduate degree from ESSEC Business School in 2001.


Photo Stanislas Coppin
Stanislas Coppin

Stanislas Coppin has founded two companies, Gust Vision, Inc. in 2019 where he holds the title of Chief Executive Officer, and Unique Entertainment Experience SAS in 2018 where he also holds the title of Chief Executive Officer.
Mr. Coppin is also the founder of Mindie, Inc.



Photo Stanislas Guy Marie Ancel
Stanislas Guy Marie Ancel

Stanislas Guy Marie Ancel is currently a Director at MES Environmental Ltd., Hanford Waste Services Ltd., CNIM Azerbaïdjan Ltd., CNIM Asia Pacific Ltd., CNIM US Corp, and Lab Us Corp.
He was previously the Chief Executive Officer-Environment & Energy at CNIM Group SA, a Director at Le Lab SA, a Co-Managing Director at LAB GmbH, and a Director at Suncnim SAS.
Ancel received his undergraduate degree from Ecole Centrale Lyon in 1998.




Photo Stanislas Vilgrain
Stanislas Vilgrain

Stanislas Vilgrain is currently the Chairman at Cuisine Solutions Europe SAS and a Director at Les Fromentiers de France SA. He was previously the Chief Executive Officer & Director at Cuisine Solutions, Inc. from 1993 to 2007.
Prior to that, he was the President-Culinary Division at Vie de France Corp.
from 1987 to 1991.


Aucun résultat pour cette recherche

  1. Bourse
  2. Recherche avancée
  3. Stanislas Veillet
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT